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Abstract
Introduction: The purpose of this study was to investigate the relationship among Pseudomonas aeruginosa
acquisition on the intensive care unit (ICU), environmental contamination and antibiotic selective pressure against
P. aeruginosa.
Methods: An open, prospective cohort study was carried out in a 16-bed medical ICU where P. aeruginosa was
endemic. Over a six-month period, all patients without P. aeruginosa on admission and with a length of stay >72 h
were included. Throat, nasal, rectal, sputum and urine samples were taken on admission and at weekly intervals
and screened for P. aeruginosa. All antibiotic treatments were recorded daily. Environmental analysis included
weekly tap water specimen culture and the presence of other patients colonized with P. aeruginosa.
Results: A total of 126 patients were included, comprising 1,345 patient-days. Antibiotics were given to 106
patients (antibiotic selective pressure for P. aeruginosa in 39). P. aeruginosa was acquired by 20 patients (16%) and
was isolated from 164/536 environmental samples (31%). Two conditions were independently associated with P.
aeruginosa acquisition by multivariate analysis: (i) patients receiving ≥3 days of antibiotic selective pressure
together with at least one colonized patient on the same ward on the previous day (odds ratio (OR) = 10.3 ((%
confidence interval (CI): 1.8 to 57.4); P = 0.01); and (ii) presence of an invasive device (OR = 7.7 (95% CI: 2.3 to 25.7);
P = 0.001).
Conclusions: Specific interaction between both patient colonization pressure and selective antibiotic pressure is
the most relevant factor for P. aeruginosa acquisition on an ICU. This suggests that combined efforts are needed
against both factors to decrease colonization with P. aeruginosa.
Introduction
Pseudomonas aeruginosa infections on the ICU are a
constant concern [1]. Colonization with this organism
often precedes infection [2] and its prevention is, there-
fore, extremely important. P. aeruginosa colonization
has been reported to originate from exogenous sources
such as tap water [3], fomites and/or patient-to-patient
transmission, or as an endogenous phenomenon related
to antibiotic use. Some studies have highlighted the
importance of exogenous colonization during hospitali-
zation (50 to 70% of all colonizations) [4-9] whereas
others have questioned its relative importance [10-13].
Molecular epidemiology techniques have given an
insight into P. aeruginosa acquisition by demonstrating
that the same pulsotypes may spread from the environ-
ment to patients [14,15], sometimes in an epidemic
mode. This could explain the discrepancies between stu-
dies with different levels of exogenous acquisition
[14-16]. Although genotyping methods are useful, they
fail in giving a definitive result for the origin of bacteria.
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any medium, provided the original work is properly cited.First, a strain shared by a patient and his/her environ-
ment has not necessarily been transmitted from the
environment to the patient. Furthermore, acquisition of
a strain not isolated from the environment does not
necessarily mean that it is part of the patient’s flora (the
classical endogenous definition [17,18]). It could also
have been acquired through previous healthcare proce-
dures from undiscovered environmental sources (mis-
diagnosed exogenous acquisition). Whatever the mode
of acquisition, the determinants of colonization remain
unclear. In particular, the role of antibiotic selective
pressure on P. aeruginosa colonization is an important
issue.
In a previous study [3], we carried out a genotypic
analysis on our medical ICU. This analysis eliminated
an exogenous epidemic spread but showed that P. aeru-
ginosa colonization was associated with tap water con-
tamination over several weeks. It suggested, together
with an overall incidence of 11.3 colonized/infected
cases per 100 patients, an endemic P. aeruginosa context
[3]. However, this study had several limitations. Only
genotyping from one colony of each culture was per-
formed so that only one-third of the strains were ana-
lysed. Thus, it was not possible to ascertain which
acquisition mechanism predominated. More impor-
tantly, the potential role of antibiotic selective pressure
on acquisition was not studied. Based on the same study
population, the aim of the current study was to explore
the respective roles of environment and antibiotic selec-
tive pressure on P. aeruginosa colonization during
healthcare delivery in these endemic conditions.
Materials and methods
Study setting
The study was performed on a 16-bed medical ICU in a
1,624-bed university teaching hospital between April
and November 2003 (29 weeks). Patients were treated in
single rooms distributed on four wards of four rooms
each. Other rooms such as a rest area, sterilization
room (a room dedicated to sterilization of medical
devices), toilet, equipment storage room, office and
night duty bedroom were shared (Figure 1). Each room
had its own water tap. The nurse:patient ratio was 1:4.
The antibiotic policy and hygiene protocols were not
modified during the study period. No digestive deconta-
mination was used on the ICU. Twice monthly chlorine
tap water disinfection was started in July (Week 11).
Hygiene protocols consisted of contact barrier precau-
tions for medical and nursing staff caring for patients
colonized or infected with multi-resistant microorgan-
isms (not including P. aeruginosa). These precautions
were applied systematically on admission of previously
hospitalized patients from other medical or surgical
units for more than 48 h and for known carriers.
P. aeruginosa carriers were identified on admission from
rectal and oropharyngeal swabs. No screening was per-
formed at discharge. Hand hygiene procedures were
emphasized routinely.
Patients
All patients admitted during the study period were sys-
tematically included in a prospective cohort. Secondary
exclusion criteria included: length of ICU stay <72 h
and carriage of P. aeruginosa on admission. These
patients were, however, considered as potential P. aeru-
ginosa environmental sources as they were present in
the ICU. Data were recorded prospectively each day
until P. aeruginosa colonization/infection, death, dis-
charge to another unit, or end of the study period. The
variables examined for all patients included demo-
graphic data (age, gender), underlying conditions
(immunosuppression as defined by cancer, AIDS with
CD4 T-lymphocytes <100, haemopathy, or corticother-
apy >0.5 mg/kg/day, diabetes mellitus, end-stage renal
disease, chronic liver disease, chronic heart or respira-
tory failure) and severity evaluated by the Simplified
Acute Physiology Score (SAPS II) [19]. Data regarding
the use of intravascular catheters, nasogastric or endo-
tracheal tubes were also collected daily.
This study was approved by our local ethics commit-
tee (Comité de Protection des Personnes Sud-Ouest et
Outre Mer III, reference number: DC2010/38). The
need to obtain informed consent was waived because no
change was done to our ICU’s usual practices (the ende-
mic context of the ICU justified an intense surveillance
procedure), but patients and/or their proxies were
informed of the study’s purpose.
Microbiological screening
As a routine surveillance procedure, throat, nasal and
rectal swabs as well as sputum and urine samples were
collected on admission and weekly thereafter on prede-
fined days. Other specimens were taken when clinically
indicated. Environmental screening included weekly tap
water samples from the patients’ rooms and tap water
samples from shared rooms every three weeks. The
methods of specimen collection and culture have been
described previously [3].
Definition of acquired P. aeruginosa colonization/infection
Acquired colonization/infection was defined as the isola-
tion of P. aeruginosa from at least one surveillance or
clinical culture from patients not colonized or infected
at ICU admission. P. aeruginosa infection was defined as
a positive culture with clinical and biological manifesta-
tions of infection. In cases of lower respiratory tract
infection, quantitative cultures were positive if a thresh-
old of ≥10
7 colony-forming units (CFU)/ml for tracheal
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4 CFU/ml for bronchoalveolar lavage
were obtained.
Risk factors for P. aeruginosa colonization/infection
Antibiotics
Antibiotic treatment was recorded daily and classified
according to P. aeruginosa susceptibility (no antibiotic
treatment, inactive or active against P. aeruginosa
including ureido and carboxypenicillins, antipseudomo-
nal cephalosporins, carbapenems, fluoroquinolones, ami-
noglycosides, colimycin, fosfomycin). If a patient was
treated simultaneously with both active and non-active
antibiotics, the patient was considered to have been
treated with active antibiotics.
Environmental factors
Systematic environmental screening included other
patients from the ward on which the patient was hospi-
talized, other patients on the ICU, tap water from the
same ward, tap water from the ICU and tap water from
shared rooms. Daily indices of environmental pressure
were calculated as assessed in other studies of patient-
induced colonization pressure [11]. Briefly, for each
study day, the number of patients and tap water samples
colonized with P. aeruginosa on the ward/ICU where
the patient was hospitalized was estimated. Two vari-
ables were then described: (i) the colonization of
patients or tap water samples on the previous day
(called previous patient/tap water colonization pressure);
and (ii) the number of patients or tap water samples
colonized since the patient’s admission (called cumula-
tive patient/tap water colonization pressure). Environ-
mental exposure was assumed to be constant between
two screenings. Hence, patients who acquired P. aerugi-
nosa had several environmental pressure profiles
(including patient colonization pressure and tap water
colonization pressure) allowing a comparison with
patients who did not acquire P. aeruginosa.
Statistical analysis
Quantitative variables were compared using the Stu-
dent’s t-test or Wilcoxon test according to the distribu-
tion of data. Qualitative variables were compared using
Figure 1 Schematic representation of the 16-bed medical ICU.
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2 or Fisher’s exact test. A marginal logistic regres-
sion model accounting for repeated measurements [20]
was used to assess the relationship between environment,
antibiotic pressure and P. aeruginosa acquisition each
day, and the results were expressed as odds ratios (OR)
and 95% confidence intervals (CI). Univariate analysis of
P. aeruginosa acquisition included: (i) fixed variables for
patient characteristics at admission; (ii) longitudinal data
on patient/tap water colonization pressures, as described
above, on the cumulative number of days since admission
with a nasogastric tube (which was selected to represent
invasive devices as it is strongly associated with the use
of other invasive devices in our clinical practice) or with
antibiotics classified as active or inactive against P. aeru-
ginosa. Selection of the environmental exposure index
(previous or cumulated colonization pressure) was based
on Akaike criteria [21]: patient/tap water colonization
pressure on the previous day was finally introduced in
the multivariate analysis. Quantitative data were analyzed
as categorical variables when the log-linearity assumption
was not followed. All factors with a P-value < 0.20 in uni-
variate analysis were selected for multivariate analysis. In
multivariate analysis, the factors related to patient/tap
water colonization pressures, that is, “patients on the
same ward”, “tap water from the ICU”, “tap water from
the shared rooms” or antibiotics were first introduced
together and forced in the model. Because wards are
included in the ICU, only the most significant index
among colonization pressure onto the ward or the ICU
was selected for analysis purpose. Other factors were
then introduced in a stepwise manner to control for con-
f o u n d i n g .A c c o r d i n gt oo u rm a i no b j e c t i v e ,t h ef i n a l
model looked for interactions between each of the three
patient/tap water colonization pressures and antibiotic
variables. A P-value of <0.05 was considered significant.
Data were recorded prospectively with Epidata (3.1;
Odense, Denmark). The model was fitted using the GEN-
MOD procedure on SAS software (SAS Institute, Inc.,
Cary, NC, USA).
Results
Study population
Of the 415 patients admitted to the ICU during the 29-
week study period, 262 were excluded because their
length of stay was <72 h and 27 were excluded because
screening at admission revealed P. aeruginosa. Finally,
126 patients were included, comprising 1,345 patient-
days. The demographic and clinical characteristics of
these patients are shown in Table 1.
Microbiological screening
During the study, microbiological screening yielded 807
samples: 166 sputum or bronchoalveolar cultures, 144
blood cultures, 114 nasal, 111 rectal, 109 throat, 108
urine and 55 miscellaneous cultures. Cultures were not
available for 15 patients, accounting for 94 patient-days.
Each patient had a median of five cultures (range: two
to nine) during their ICU stay. Acquired P. aeruginosa
was present in 27 cultures (3.4%): 11 respiratory, 7 rec-
tal, 4 throat and 3 nasal cultures, 1 stool and 1 perito-
neal sample.
Acquired colonization/infection
Twenty patients (16%) acquired P. aeruginosa during
their ICU stay. P. aeruginosa colonization was present in
11 patients: rectal culture (n = 5), sputum culture (n =
2), rectal and throat or nasal culture (n = 2), sputum cul-
ture associated with rectal, nasal and throat colonization
(n = 1) and stool culture (n = 1). P. aeruginosa infection
was observed in nine other patients (nosocomial pneu-
monia (n = 8) and nosocomial peritonitis (n =1 ) ) .P. aer-
uginosa isolation occurred a median of 11 days (range: 8
to 16) after admission.
Antibiotic treatment
During their ICU stay, 106 patients (84%) received a
total of 970 antibiotic days with a median of two anti-
biotics (range: one to three) for a median duration of
Table 1 Demographic and clinical characteristics of the
study population (n = 126)
Characteristic
Age (years) 57 ± 17
Male/female 72/54
SAPS II 45 ± 18
Hospitalization before admission 88 (70.0%)
Underlying conditions 0.7 ± 0.7
immunosuppression 29 (23.0%)
chronic respiratory failure 24 (19.0%)
diabetes 22 (17.5%)
heart disease 4 (3.2%)
renal disease 4 (3.2%)
cirrhosis 2 (1.6%)
Invasive device
Mechanical ventilation (%) 78
Duration (days) 6 (2 to 10)
Central venous catheter (%) 65
Duration (days) 5 (0 to 10)
Nasogastric tube (%) 72
Duration (days) 6 (0 to 10)
Enteral nutrition (%) 93
Duration (days) 6 (4 to 9)
Foley catheter (%) 79
Duration (days) 6 (2 to 11)
Length of stay (days) median 8 (6 to 12)
ICU mortality 29 (23%)
Values are shown as mean ± SD, n (%), or median (1
st to 3
rd quartile).
SAPS II: Simplified Acute Physiology Score; ICU: intensive care unit.
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used are described in Table 2. All patients who acquired
P. aeruginosa (except one) had received antibiotics
before acquisition (median of two antibiotics (two to
four) vs. median of two antibiotics (two to three) in the
other group; P = 0.09). Among the 106 patients treated
with antibiotics, two-thirds (n = 67) received at least
one day of antibiotics active against P. aeruginosa
whereas one-third (n = 39) did not.
Environmental screening results
The results of environmental screening are shown in
Table 3. In addition to the 20 patients who acquired P.
aeruginosa during the study, 27 patients were colonized
and/or infected with P. aeruginosa at ICU admission.
Thus, 47 patients potentially contributed to the patient
colonization pressure. Tap water screening from the
patient’s rooms yielded 152/464 positive samples (33%).
Surveillance of tap water from shared rooms yielded 72
samples, of which 12 were positive for P. aeruginosa
(17%). Contaminated tap water was observed four times
in the shared toilet, three times in the sterilization
room, twice in the night duty bedroom and once in the
rest area, office or equipment storage room. The imple-
mentation of tap water disinfection at Week 11 of the
study should have decreased the patients’ environmental
pressure. However, no significant interaction was found
between tap water colonization and time period (before
or after Week 11) (P = 0.69).
Risk factors for P. aeruginosa acquisition
By univariate analysis, the presence of an invasive device
(nasogastric tube), previous patient colonization pressure
on the same ward and previous tap water colonization
pressure from the ICU and shared rooms were signifi-
cantly associated with P. aeruginosa acquisition (Table 4).
Multivariate analysis revealed that the presence of a naso-
gastric device was independently associated with P. aeru-
ginosa acquisition (OR = 7.72 (95% CI: 2.32 to 25.70); P =
0.001). In addition, the interaction between antibiotics
inactive against P. aeruginosa and the patient coloniza-
tion pressure was also significant (P < 0.03). It means
Table 2 Distribution of antibiotic treatment according to acquisition group*
P. aeruginosa acquisition
n = 20 (%)
No P. aeruginosa acquisition
n = 106 (%)
Total n = 126
(%)
Antibiotics active against P. aeruginosa 10 (50) 57 (54) 67 (53)
Aminosides 6 (30) 17 (16) 23 (18)
Ureido/carboxypenicillins 5 (25) 19 (18) 24 (19)
Piperacillin-tazobactam 5 (25) 12 (11) 17 (13)
Ticarcillin-clavulanic acid 0 (0) 7 (7) 7 (6)
Antipseudomonal cephalosporins 3 (15) 13 (12) 16 (13)
Ceftazidime 3 (15) 6 (6) 9 (7)
Cefepime 0 (0) 7 (7) 7 (6)
Carbapenems 4 (20) 12 (11) 16 (13)
Fluoroquinolones 7 (35) 33 (31) 40 (32)
Others 1 (5) 3 (3) 4 (3)
Fosfomycin 0 (0) 2 (2) 2 (2)
Colomycin 1 (5) 1 (1) 2 (2)
Antibiotics not active against P. aeruginosa 14 (70) 85 (80) 99 (79)
Glycopeptides 5 (25) 30 (28) 35 (28)
Non-antipseudomonal penicillins 4 (20) 43 (41) 47 (37)
Penicillin G 0 (0) 1 (1) 1 (1)
Penicillin M 0 (0) 2 (2) 2 (2)
Amoxicillin 1 (5) 3 (3) 4 (3)
Amoxicillin-clavulanic acid 3 (15) 37 (35) 40 (32)
Non-antipseudomonal cephalosporins (cefotaxim; cefuroxim;
ceftriaxon)
10 (50) 23 (22) 33 (26)
Macrolides 5 (25) 12 (11) 17 (13)
Other 2 (10) 18 (17) 20 (16)
Pristinamycin 0 (0) 3 (3) 3 (2)
Metronidazole 0 (0) 10 (9) 10 (8)
Cotrimoxazole 1 (5) 1 (1) 2 (2)
Rifampicin 1 (5) 4 (4) 5 (4)
* The data represent the number of patients who received at least one day of antibiotic of each class (percentage of patients in each group).
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days of antibiotics inactive against P. aeruginosa, the pre-
sence of at least one colonized patient on the same ward
on the previous day increased the risk of P. aeruginosa
acquisition on a given day (OR = 10.26 (95% CI: 1.83 to
57.43); P = 0.01) compared to patients without colonized
patient in the same ward. This association was not
observed in patients with less than three days of antibio-
tics inactive against P. aeruginosa.
Discussion
This study suggests two main conclusions. First, P. aeru-
ginosa acquisition should be related to the proximity of
a patient colonized with P. aeruginosa in the area (same
room) with a chronological component (the previous
day) along with selective antibiotic pressure. Antibiotic
selective pressure alone did not influence P. aeruginosa
acquisition. The hypothesis of a complex mechanism
involving antibiotic selective pressure and patient colo-
nization pressure should be relevant for P. aeruginosa
a c q u i s i t i o ni na nI C Uw i t he n d e m i cc o n t e x t .I ft h e
interaction of both pressures overriding each pressure
taken separately is reviewed, there could be some practi-
cal implications. Developing strategies for either
decreased antibiotic use for “endogenous-like” acquisi-
tion or hygiene improvement in response to environ-
mental contamination in “exogenous-like” acquisition
could be insufficient. In an endemic ICU without
obvious epidemic acquisition, it is arguable that a reduc-
tion in antibiotic selective pressure and improvement in
hygiene standards should be combined. The second con-
clusion is that invasive devices remain an important
determinant in P. aeruginosa acquisition. Whether inva-
sive devices are a surrogate of patient’s severity (an
already known acquisition risk factor) or a step for bac-
teria in the chain linking the environment to the
patients cannot be inferred from the results of this
study.
In our study, the classical binary endogenous/exogenous
scheme [12,22] is transcended by the interaction of both
factors, which confirms that P. aeruginosa acquisition is
complex. In the past, some molecular epidemiology
Table 3 Summarization of environmental screening data according to acquisition group
P. aeruginosa acquisition
(n = 20)
No P. aeruginosa
acquisition (n = 106)
Total (n = 126)
Cumulative patient-induced environmental pressure*
From the same ward 1.2 (0.6 to 1.8) 0.8 (0 to 1.7) 1 (0.1 to 1.8)
From the ICU 4.8 (3.6 to 5.6) 4.7 (3.3 to 5.6) 4.7 (3.3 to 5.6)
Cumulative tap water-induced environmental pressure*
From the patients’ wards 0.1 (0 to 0.7) 0 (0 to 0.6) 0 (0 to 0.6)
From the ICU 1.9 (1.1 to 2.3) 1.6 (0 to 3) 1.8 (0 to 2.9)
From shared rooms 1 (0.7 to 2.3) 0.8 (0 to 1) 1 (0 to 1)
Patient-induced environmental pressure**
≥1 colonized patient on the same ward
yes 20 79 99
no 0 27 27
≥1 colonized patient on the ICU
yes 20 106 126
no 0 0 0
Tap water-induced environmental pressure**
≥1 colonized tap water on the same ward
yes 10 51 61
no 10 55 65
≥1 colonized tap water on the ICU
¤
yes 18 68 86
no 2 38 40
≥1 colonized tap water in shared rooms
yes 17 70 87
no 3 36 39
Values shown are: median (1
st to 3
rd quartile), or n.
*Cumulative patient/tap water-induced environmental pressure represents the number of contaminated patients/tap water samples since admission.
**Patient/tap water-induced environmental pressure represents the number of patient that were exposed to a contaminated patient/tap water at least one time
during their ICU stay.
¤ Excluding tap water in shared rooms.
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nization [4-7,18], whereas others have predominantly
identified the role of endogenous colonization [11,13].
Genotypic methods may detect an epidemic context
where exogenous sources are the most important [23] and
potentially overestimate its role. Hence, the same group
has described two different levels of exogenous P. aerugi-
nosa cross-transmission [9,11]. It is also likely that strains
spread rapidly from patients to the environment and vice-
versa, complicating environmental and patient screening
because screening at distinct time intervals could misclas-
sify some cases of exogenous acquisition [16]. Special
attention should also be paid to so-called “endogenous”
P. aeruginosa acquisition. P. aeruginosa is not generally
considered to be part of the normal human flora [16], and
in most patients admitted to hospital for the first time,
P. aeruginosa is not usually isolated from bacteriological
specimens until the patient has been in the hospital for
several days [22,24,25]. In these cases it is unclear if P. aer-
uginosa is really endogenous (that is, present on admission
but undetected by screening and only revealed by antibio-
tic selective pressure) [17,18]. On the other hand, despite
being absent from the flora on admission, P. aeruginosa
could be acquired from the environment through
Table 4 Risk factors for P. aeruginosa acquisition in the ICU (n = 126)
Univariate analysis Multivariate analysis
Risk factor OR (95% CI) P OR (95% CI) P
SAPS II
≥43 (vs. <43) 2.54 (0.89 to 7.24) 0.08 *
Age
≥70 years (vs. <70) 4.61 (1.67 to 12.72) 0.14 *
Nasogastric tube
Equal to or more than nine cumulated days since admission
(vs. less than nine days)
7.66 (2.88 to 20.36) <0.0001 7.72 (2.32 to 25.70) 0.001
Antibiotic treatment not active against P. aeruginosa
More than three days (vs. zero to two days) 2 (0.76 to 5.27) 0.16 ***
Antibiotic treatment active against P. aeruginosa**
per cumulated day since admission 1.02 (0.95 to 1.10) 0.54 ****
Previous patient-induced environmental pressure
Equal to or more than one colonized patient on the same
ward on the previous day (vs. zero)
4.91 (1.47 to 16.39) 0.01 ***
Equal to or more than one colonized patient on the ICU on
the previous day (vs. zero)
1.14 (0.27 to 4.90) 0.86 ****
Previous tap water-induced environmental pressure
Equal to or more than one colonized tap water on the same
ward on the previous day (vs. zero)
2.37 (0.96 to 5.89) 0.06
$
Equal to or more than one colonized tap water on the ICU
on the previous day (vs. zero)
3.79 (1.26 to 11.44) 0.02 1.99 (0.67 to 5.88) 0.21
Equal to or more than one colonized tap water in shared
rooms on the previous day (vs. zero)
4.63 (1.37 to 15.65) 0.01 3.07 (0.93 to 10.16) 0.07
Interaction between previous patient-induced environmental
pressure and inactive antibiotics:
0.03
$$
If equal to or more than three days of inactive antibiotics 1
- no colonized patient on the same ward on the
previous day
10.26 (1.83 to 57.43) 0.01
- equal to or more than one colonized patient on the
same ward on the previous day
If zero to two days of inactive antibiotics
- no colonized patient on the same ward on the
previous day
1
- equal to or more than one colonized patient on the
same ward on the previous day
1.00 (0.26 to 3.87) 0.99
*Factors removed by stepwise forward procedure.
**Log-linearity was assumed for this factor.
***Factors included in the interaction.
****Not statistically eligible by univariate analysis (P > 0.20).
$Not included in multivariate analysis for colinearity with tap water in the ICU.
$$P for overall interaction.
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with P. aeruginosa isolation from oropharyngeal samples
before the gastrointestinal tract support this hypothesis
[26]. Moreover, Johnson et al. [22] recently observed that
50% of imipenem-resistant P. aeruginosa acquisition corre-
sponded to neither the classical endogenous nor exogen-
ous route. The question of an undiscovered environmental
source was raised. This is the case in some endemic ICU
contexts [27]. In our ICU the endemic context was sug-
gested by the fact that one-third of the strains shared the
same genotypic profile without an obvious exogenous
source of acquisition or epidemic profile [3].
Irrespective of the obvious, undiscovered exogenous or
true endogenous source of P. aeruginosa [28], it is likely
that acquisition of this microorganism by patients is
related to a third factor, namely antibiotic treatment
which could interact with the environment to facilitate
P. aeruginosa acquisition. Our study confirms this
hypothesis. It focused on individual patients with daily
recorded antibiotic treatment rather than on a popula-
tion with collective consumption data [29]. Daily anti-
biotic recording does not prevent misclassification of
antibiotic treatment as active, whereas it was eventually
inactive due to poor PK/PD optimization. Even if there
is still poor knowledge of the optimal antibiotic dosing
strategies to prevent the selection of resistance, an anti-
biotic stewardship designed to limit insufficient antibio-
tic doses was set up at the study period, potentially
limiting this bias. Besides, all previously known risk fac-
tors were adjusted for, as well as widespread and
repeated patient and tap water screening (including
samples from shared rooms), which have not always
been completely (only patient-to-patient transmission)
[11,18] or properly (type and frequency of environmen-
tal screening) [10,13] assessed. Moreover, active antibio-
tics were distinguished from inactive antibiotics
(selective antibiotic pressure), which could help P. aeru-
ginosa become dominant in the patients’ flora.
In our ICU, as potentially in others with the same
endemic and antibiotic consumption profiles, the results
of this study will lead to the development of coordinated
strategies against the use of antibiotics that are inactive
against P. aeruginosa (such as a decrease in systematic
penicillin or cephalosporin treatment for aspiration
pneumonia) and against the environmental spread of
bacteria. The latter should include alcohol-based hand-
cleaning programmes since cross-contamination
between patients and contaminated tap water was sus-
pected in our study. Contaminated tap water and
patients’ samples were associated with P. aeruginosa
acquisition in univariate analysis but only patients’ sam-
ples were significant in multivariate analysis. Positive
cultures from shared rooms were associated with
P. aeruginosa acquisition in univariate analysis and
should be interpreted as additional to ICU P. aeruginosa
colonization pressure.
There are several limitations to our study. It was a sin-
gle-centre study and the limited observations may give
reduced power to detect other contributing risk factors.
These limitations prevent its application to other ICUs
where the patient case mix, prevalence of P. aeruginosa
colonization at admission and antibiotic consumption are
different. Antibiotic selective pressure could have played
a role in revealing a pre-existing P. aeruginosa flora
shared with the patient’s environment without a cause-
and-effect relationship (which would only have been
demonstrated by chronological acquisition of the same
genotypic strain) or in rendering the patient susceptible
to P. aeruginosa acquisition from the environment. Other
limitations include the fact that adherence to hygiene
rules was not assessed, antibiotic consumption before
admission was not recorded and P. aeruginosa screening
was not performed at the end of the ICU stay. Moreover,
the environment (patients and tap water) was screened
by intermittent samples. However, the inclusion in the
model of the most recent sample provided a closer analy-
sis of the time-dependent process of acquisition. Finally,
routine surveillance cultures were not obtained from 15
patients with a short stay, although this probably did not
significantly influence our findings as they accounted for
only 7% of total patient-days.
Conclusions
In conclusion, this study adds further support for an
interaction between the patient colonization pressure
and antibiotic selective pressure in the process of P. aer-
uginosa acquisition in the ICU. These results should be
confirmed in a larger study in order to generalize their
potential implications (that is, target strategies aimed at
decreasing antibiotic treatment, where possible, and
improving hygiene protocols).
Key messages
￿ Pseudomonas aeruginosa is still a leading cause of
nosocomial infections, yet its mode of acquisition
remains the subject of debate.
￿ In a given patient, the interaction between the
environment and the selective antibiotic treatment
he (she) just received deserves more study.
￿ This single-centre ICU-based study shows that a
specific interaction between both patient coloniza-
tion pressure and selective antibiotic pressure is the
most relevant factor for P. aeruginosa acquisition.
￿ Prevention of acquisition in a given patient should
include both antibiotic stewardship and cross-trans-
mission prevention.
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